PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Day-long conference addresses difficult to diagnose lung disease

2025-04-26
(Press-News.org) 26 April 2025, Boston—Chronic thromboembolic pulmonary hypertension (CTEPH) often goes undiagnosed for years, is frequently caught late, and primarily affects young, otherwise healthy individuals. Even when diagnosed, finding the right treatment can be challenging.

 

At this year’s Annual Meeting and Scientific Sessions of the International Society for Heart and Lung Transplantation (ISHLT), a day-long CTEPH conference—co-sponsored by ISHLT and the International CTEPH Association (ICA) —brought together worldwide experts who presented ground-breaking outcomes research on treatments for the disease.

 

“In the past, patients with CTEPH were, on average, misdiagnosed for several years,” said presenter Michael M. Madani, MD, FACS, Executive Director-Surgery, UC San Diego Health Cardiovascular Institute and co-chair of the CTEPH conference. “Due to educational events like this, it’s down to about 12-18 months.

 

“Unfortunately, we still see patients who’ve been treated for asthma, COPD, and obesity for years before someone considers CTEPH,” he said.

 

The session covered new medications, refined treatment techniques, innovative treatment approaches, and case-based clinical decision-making.

 

Key takeaways

The Cause of CTEPH

Old blood clots, or pulmonary embolisms (PEs), get trapped in the blood vessels of the lung. Some resolve on their own while large PEs may be lethal. In patients with CTEPH, chronic unresolved PEs form scar tissue inside the vessels. CTEPH Diagnosis

The average length of misdiagnosis has decreased from years to approximately 12-18 months  The overall incidence rate is about 2-5 percent but may be increasing due to better recognition. It’s critically important for physicians to consider other factors leading to clot formation in the lungs About 50 percent of patients who experience CTEPH have no history of deep vein thrombosis or acute PE Patients with pacemakers and other intravenous catheters or devices may be prone to clots in the lung vessels Radiologists must be trained to detect small chronic clots in the lung vessels on CT scans CTEPH by the Numbers

Accounts for up to 15 percent of pulmonary hypertension patients Affects men and women equally The median age of patients is 50. Dr. Madani has operated on patients as young as six and as old as 90 The number of CTEPH surgeries (to remove scar tissue from the lung vessels, called a pulmonary endarterectomy) performed in the US has roughly doubled in the past decade. Most CTEPH patients who undergo successful surgery can live a normal lifestyle.  

END

About ISHLT
The International Society for Heart and Lung Transplantation (ISHLT) is a not-for-profit, multidisciplinary, professional organization dedicated to improving the care of patients with advanced heart or lung disease through transplantation, mechanical support, and innovative therapies via research, education, and advocacy. ISHLT members focus on transplantation and a range of interventions and therapies related to advanced heart and lung disease.

The ISHLT Annual Meeting and Scientific Sessions will be held from 27-30 April at the John B. Hynes Veterans Memorial Convention Center in Boston.

 

Contact:

Jess Burke, Director of Marketing and Communications
+1.312.224.0015
jess.burke@ishlt.org

 

END



ELSE PRESS RELEASES FROM THIS DATE:

First-ever cardiogenic shock academy features simulation lab

2025-04-26
26 April 2025, Boston—Healthcare practitioners from around the world received hands-on training for treating patients in cardiogenic shock (CS) during a first-ever simulation lab at today’s Annual Meeting and Scientific Sessions of the International Society of Heart and Lung Transplantation (ISHLT) in Boston. The simulation lab was part of ISHLT’s inaugural Cardiogenic Shock Academy, a day-long session featuring a case-based forum and discussion of hot topics and anticipated developments ...

Thirty-year mystery of dissonance in the “ringing” of black holes explained

2025-04-26
Tokyo, Japan – A scientist from Tokyo Metropolitan University has solved the longstanding problem of a “dissonance” in gravitational waves emitted by a black hole. Using high precision computing and a new theoretical physics framework, it was discovered that it was caused by a resonance between a pair of distinctive “modes” i.e. different ways in which a black hole can “ring.” The phenomenon offers new insights into the nascent field of black hole spectroscopy.   Black holes are astrophysical objects so dense that even light cannot escape their gravitational pull. Despite their awesome presence ...

Less intensive works best for agricultural soil

2025-04-26
The less intensively you manage the soil, the better the soil can function. Such as not ploughing as often or using more grass-clover mixtures as cover crops. These are the conclusions from a research team led by the Netherlands Institute of Ecology (NIOO-KNAW). Surprisingly, it applies to both conventional and organic farming. These important insights for making agriculture more sustainable are published in the scientific journal Science today. ‘It offers clear evidence to help farmers manage soils better.’ Growing food more sustainably: what's the best way to do this? It is ...

Arctic rivers project receives “national champion” designation from frontiers foundation

2025-04-26
WOODS HOLE, Mass. -- The Frontiers Planet Prize, the world’s largest science competition to enhance planetary health by fast-tracking innovative research, has announced National Champions from 19 different countries who now advance to the International competition, which will award three winners $1M each to scale up their research. Suzanne Tank and co-authors from the Arctic Great Rivers Observatory (ArcticGRO), a multinational project founded at the Marine Biological Laboratory (MBL), were recognized for their publication, “Recent trends in the chemistry of major northern rivers signal widespread Arctic change,” published ...

Computational biology paves the way for new ALS tests

2025-04-25
Amyotrophic lateral sclerosis (ALS) is a disease that destroys the nerves necessary for movement. About 30,000 people in the United States are affected, and doctors still don’t know what causes it. To lay the groundwork for better tests, Thomas Jefferson University researchers Phillipe Loher, Eric Londin, PhD, and Isidore Rigoutsos, PhD are taking a computational biology approach to see how ALS affects molecules in the blood. In a study published in Molecular Neurobiology, the team analyzed blood samples from about 300 people with and without ALS. The research focused on small non-coding ...

Study offers new hope for babies born with opioid withdrawal syndrome

2025-04-25
As the opioid crisis continues, the number of babies born with neonatal opioid withdrawal syndrome (NOWS) – a condition that affects infants whose mothers used opioids during pregnancy – has risen 5-fold over the past 20 years. According to the Centers for Disease Control (CDC), there are 20,000 infants a year in the United States born with signs of NOWS. These infants often require extended hospital stays and, in some cases, treatment with medications like morphine to relieve withdrawal symptoms. A new study from Walter Kraft, MD, an internist and clinical pharmacologist at Thomas Jefferson University, ...

UT, Volkswagen Group of America celebrate research partnership

2025-04-25
Leadership from the University of Tennessee, Knoxville, Volkswagen Group of America and Oak Ridge National Laboratory celebrated more than a decade of collaboration and the fifth anniversary of the Volkswagen Innovation Hub Knoxville on April 24. Since 2011, UT and Volkswagen have partnered on strategic research projects that have accelerated the discovery and commercialization of new technology, including battery performance, materials science, power electronics and mobility ...

New Medicare program could dramatically improve affordability for cancer drugs – if patients enroll

2025-04-25
PHILADELPHIA – Even for patients covered by Medicare, annual out-of-pocket costs for lifesaving cancer treatments taken in pill form have often exceeded $10,000—until recently. Thanks to changes in Medicare Part D introduced by the Inflation Reduction Act (IRA) that took effect in 2025, annual out-of-pocket drug costs for all beneficiaries are now capped at $2,000. However, an overlooked voluntary program that’s part of the IRA could be the key to improving affordability for Medicare patients needing expensive oral cancer drugs, according to a new study from researchers ...

Are ‘zombie’ skin cells harmful or helpful? The answer may be in their shapes

2025-04-25
Senescent skin cells, often referred to as zombie cells because they have outlived their usefulness without ever quite dying, have existed in the human body as a seeming paradox, causing inflammation and promoting diseases while also helping the immune system to heal wounds.  New findings may explain why: Not all senescent skin cells are the same. Researchers from Johns Hopkins University have identified three subtypes of senescent skin cells with distinct shapes, biomarkers, and functions—an advance that could equip scientists with the ability to target and kill the harmful types while leaving the helpful ones intact.  The findings were published today ...

University of Cincinnati Cancer Center presents research at AACR 2025

2025-04-25
University of Cincinnati Cancer Center researchers will present abstracts at the American Association for Cancer Research Annual Meeting 2025 in Chicago. Study finds contrasting effects of protein on head and neck cancer A small protein called IL-9 has been shown to either contribute to or counteract tumor growth depending on the type of cancer, but its role in head and neck cancer has not been studied. Abstract lead author Sam Nusbaum and her colleagues found IL-9 levels are increased in patients with head and neck cancer compared to healthy controls.  “High ...

LAST 30 PRESS RELEASES:

Cercus electric stimulation enables cockroach with trajectory control and spatial cognition training

Day-long conference addresses difficult to diagnose lung disease

First-ever cardiogenic shock academy features simulation lab

Thirty-year mystery of dissonance in the “ringing” of black holes explained

Less intensive works best for agricultural soil

Arctic rivers project receives “national champion” designation from frontiers foundation

Computational biology paves the way for new ALS tests

Study offers new hope for babies born with opioid withdrawal syndrome

UT, Volkswagen Group of America celebrate research partnership

New Medicare program could dramatically improve affordability for cancer drugs – if patients enroll

Are ‘zombie’ skin cells harmful or helpful? The answer may be in their shapes

University of Cincinnati Cancer Center presents research at AACR 2025

Head and neck, breast, lung and survivorship studies headline Dana-Farber research at AACR Annual Meeting 2025

AACR: Researchers share promising results from MD Anderson clinical trials

New research explains why our waistlines expand in middle age

Advancements in muon detection: Taishan Antineutrino Observatory's innovative top veto tracker

Chips off the old block

Microvascular decompression combined with nerve combing for atypical trigeminal neuralgia

Cutting the complexity from digital carpentry

Lung immune cell type “quietly” controls inflammation in COVID-19

Fiscal impact of expanded Medicare coverage for GLP-1 receptor agonists to treat obesity

State and sociodemographic trends in US cigarette smoking with future projections

Young adults drive historic decline in smoking

NFCR congratulates Dr. Robert C. Bast, Jr. on receiving the AACR-Daniel D. Von Hoff Award for Outstanding Contributions to Education and Training in Cancer Research

Chimpanzee stem cells offer new insights into early embryonic development

This injected protein-like polymer helps tissues heal after a heart attack

FlexTech inaugural issue launches, pioneering interdisciplinary innovation in flexible technology

In Down syndrome mice, 40Hz light and sound improve cognition, neurogenesis, connectivity

Methyl eugenol: potential to inhibit oxidative stress, address related diseases, and its toxicological effects

A vascularized multilayer chip reveals shear stress-induced angiogenesis in diverse fluid conditions

[Press-News.org] Day-long conference addresses difficult to diagnose lung disease